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A 37-year-old woman with end-stage kidney failure from vesicouretheral reflux received her second 
cadaveric renal allograft in January 2006. The maintenance immunosuppressive protocol consisted of 
tacrolimus, mycophenolate mofetil and steroids. She had stable graft function with a serum creatinine 
of 110 µmol/l. In August 2006, she noticed a mass on her forehead that was painless and movable. 
However, the tumor was fast-growing and 1 month later became purple and painful causing swelling 
of the periorbital area (Figure 1a). Computed tomography imaging revealed a subcutaneous soft 
tissue mass without bony invasion (Figure 1b). A biopsy of the mass was performed, which showed 
atypical lymphoid cells that were positive for CD20 antigen (Figure 1c) and negative for CD3, 
suggestive of post-transplant lymphoproliferative disease (PTLD). The patient had no systemic 
manifestations of lymphoma. Computed tomography of thorax and abdomen and sternal puncture 
excluded other sites of involvement by post-transplant lymphoproliferative disease. Tacrolimus and 
mycophenolate mofetil were reduced by 50%, and methylprednisolone was continued (10 mg/day). 
She received six cycles of CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) 
followed by local irradiation. A computed tomography scan performed 2 months following the end of 
treatment demonstrated complete remission of post-transplant lymphoproliferative disease. Allograft 
function remained stable. 
 
To our knowledge, this is the first case of B-cell post-transplant lymphoproliferative disease 
presenting as a subcutaneous mass and demonstrates that this diagnosis should be considered in 
working up such patients. 
 
 
 
 
 
 
 
Figure 1 
 
Diagnostic evaluation. 
 
(a) Photograph of the patient’s forehead. Purple solitary nodule is compressing the periorbital tissue 
producing swelling of the periorbital area. 
 
 
 
 
 
 
(b) Computed tomography scan demonstrating the subcutaneous mass on the forehead that did not 
invade bones.  
 
 
 
 
 
 
 
 
 
 
 
 
 
(c) Tumor biopsy finding. Dense infiltrate of atypical lymphoid cells positive for CD20, indicating B 
lymphocytes (immunoperoxidase stain, magnification x 40). 
 
 
